Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Medivir reports net sales of SEK 444.6 m for 1 January - 30 June 2011

Medivir: Interim period (January 2011 - June 2011). Net sales were SEK 444.6 (35.7) m.

31 Aug 2011

Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that results from the Phase 2 clinical trial of LX1031 in patients with non-constipating irritable bowel syndrome (IBS) were published earlier this week in the August 2011 edition of the journal Gastroenterology.

11 Aug 2011

Common culinary spice derivative could treat tendinitis

A derivative of a common culinary spice found in Indian curries could offer a new treatment hope for sufferers of the painful condition tendinitis, an international team of researchers has shown.

9 Aug 2011

Positive data from Lexicon LX1032 Phase 2 study on carcinoid syndrome

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced positive, top-line proof-of-concept data from its recently completed Phase 2 study in carcinoid syndrome with LX1032, telotristat etiprate. Carcinoid syndrome is a chronic condition caused by neuroendocrine tumors that usually originate from the gastrointestinal tract.

9 Aug 2011

Lexicon's second quarter revenues decrease 55% to $0.6 million

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three and six months ended June 30, 2011.

9 Aug 2011

Ironwood licenses worldwide rights to Depomed's Acuform drug delivery technology

Ironwood Pharmaceuticals, Inc. and Depomed, Inc. today announced that Ironwood has licensed worldwide rights to utilize Depomed's Acuform gastric retentive drug delivery technology for an Ironwood early stage development program, continuing Ironwood's efforts to augment its development pipeline beyond linaclotide.

28 Jul 2011

UCLA's new center to explore links between brain, digestive system in chronic disorders

Investigators at UCLA's Center for Neurobiology of Stress have been studying the links between the brain and digestive system in the development and treatment of common chronic digestive disorders in adults and children.

16 Jun 2011

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Ganeden Biotech announced the sale of its leading Sustenex® and Digestive Advantage® brands of probiotic dietary supplements to Schiff Nutrition International, Inc. for $40 million in cash. Ganeden will also receive royalties on Schiff products containing GanedenBC30™.

6 Jun 2011

AAPA recognizes nation's top five Physician Assistants with PAragon Awards

The American Academy of Physician Assistants today recognizes five of the nation's top PAs with the Academy's highest honor, the PAragon Awards.

31 May 2011

New book on 'Overcoming Anxiety, Worry, and Fear'

Severe anxiety can leave its sufferers paralyzed with debilitating worry, uncontrollable fear and clinical depression. Although anxiety is the most common mental health problem in the U.S., many affected by anxiety don't know how to treat their problem or even how to seek help.

26 May 2011

Synergy expands GC-C agonist technology to lower cholesterol

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.

18 May 2011

Gut bacteria influences brain chemistry and behaviour: Research

For the first time, researchers at McMaster University have conclusive evidence that bacteria residing in the gut influence brain chemistry and behaviour.

18 May 2011

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people.

12 May 2011

UNC researchers present latest advances in GI, medicine and technology at DDW 2011

Digestive Disease Week is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

10 May 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Sucampo Pharmaceuticals, Inc. and Abbott today reported data from a phase 3 clinical efficacy trial in 124 Japanese chronic idiopathic constipation patients as well as from a phase 3 long-term safety trial in an additional 209 Japanese CIC patients.

10 May 2011

Parasites in human waste fertilizers alarm health experts

It has been suggested that human faeces used as fertiliser on farms are leading to the spread of ‘Third World’ parasites causing a serious stomach illness across Sydney.

8 May 2011

Devrom is effective for eliminating flatulence, stool odor issues

Flatulence. Everyone has it. Common factors contributing to flatus production are swallowed air and digestion of certain foods in the intestine. Perhaps one of the most embarrassing aspects of flatulence is the smelly odor, but there is a remedy and it is called Devrom.

5 May 2011

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre at its corporate headquarters in Belleville, Ontario, Canada.

30 Apr 2011

GPs could offer simple test for early detection of ovarian cancer

Health experts have said that hundreds of lives could be saved a year if GPs were quicker to spot symptoms of the disease - dubbed a “silent killer” because it is hard to diagnose early enough. Ovarian cancer kills almost 4,400 women in Britain every year. It kills one every two hours that makes it the fourth most common cancer in females. While almost three times as many die from breast cancer, those diagnosed with ovarian cancer are far more likely to die earlier.

28 Apr 2011

How peppermint helps to relieve Irritable Bowel Syndrome

University of Adelaide researchers have shown for the first time how peppermint helps to relieve Irritable Bowel Syndrome, which affects up to 20% of the population.

20 Apr 2011

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Medivir reports net sales of SEK 444.6 m for 1 January - 30 June 2011

Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS

Common culinary spice derivative could treat tendinitis

Positive data from Lexicon LX1032 Phase 2 study on carcinoid syndrome

Lexicon's second quarter revenues decrease 55% to $0.6 million

Ironwood licenses worldwide rights to Depomed's Acuform drug delivery technology

UCLA's new center to explore links between brain, digestive system in chronic disorders

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

AAPA recognizes nation's top five Physician Assistants with PAragon Awards

New book on 'Overcoming Anxiety, Worry, and Fear'

Synergy expands GC-C agonist technology to lower cholesterol

Gut bacteria influences brain chemistry and behaviour: Research

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

UNC researchers present latest advances in GI, medicine and technology at DDW 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Parasites in human waste fertilizers alarm health experts

Devrom is effective for eliminating flatulence, stool odor issues

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

GPs could offer simple test for early detection of ovarian cancer

How peppermint helps to relieve Irritable Bowel Syndrome

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in